Business & Finance

TAPinto Local News Network Breaks 7M Readers, 23.7M Pageviews

00e7ea30696bc57b4665_Franchise_FB_Size-02.jpg
00e7ea30696bc57b4665_Franchise_FB_Size-02.jpg

NEW PROVIDENCE, NJ - TAPinto.net, a network of more than 70 online hyperlocal news sites in New Jersey and New York, broke 7 million readers and 23.7 million pageviews during the last year. 

From Jan. 8, 2017 to Jan. 7, 2018, TAPinto registered 7,025,372 readers and 23,792,903 pageviews, up from 5,352,395 readers and 18,496,885 pageviews during the same period a year ago. During the same period, TAPinto grew from 54 sites to 71, 66 of which are currently franchised to local owner/publishers.

"At a time when many news organizations have reduced or eliminated their local news coverage, TAPinto is providing original local news coverage on a daily basis in our communities," said Chief Executive Officer and Publisher Michael Shapiro. "While other publications are engaging in clickbait and content aggregation in a quest for pageviews, we are providing a sustainable path forward, demonstrating that you can generate large traffic numbers without sensationalizing the news or becoming the neighborhood gossip page."

Sign Up for E-News

TAPinto provides the backend training and support to its franchisees. Current franchisees include business development executives, marketing and communications professionals, hardcopy newspaper publishers, public relations firms, veteran journalists, attorneys, financial advisors, Realtors, the Plainfield YMCA and St. Bonaventure University.  

"TAPinto sites are locally owned and operated and do their own original local news reporting," said Shapiro. "That local ownership and local reporting makes all the difference."

TAPinto.net, which began in 2008 as an all-online local newspaper in New Providence founded by Michael and Lauryn Shapiro, is now the largest local news network in New Jersey. TAPinto provides original local news reporting on a daily basis in more than 100 towns. It is growing while other media organizations are slashing local news coverage, regionalizing coverage, and laying off journalists.     

"We've created a growing and successful network of online local news sites that has become a model for the struggling media industry," Shapiro said. "Our innovative model enables our sites to not only produce great original local news content but to also achieve record-breaking traffic and financial sustainability."

"As we begin 2018, we look forward to continued expansion into new communities while providing our readers with the high quality news and information that they deserve. Thank you to our readers and our advertisers for your loyalty and support. We would not be here without you." 

For more information on franchising TAPinto in your area, click here

TAP Into Another Town's News:

You May Also Be Interested In

Sign Up for E-News

Flemington/Raritan

Upcoming Events

Tue, January 23, 2:30 PM

Flemington Free Public Library, Flemington

Children's Movie

Arts & Entertainment

Sat, January 27, 10:00 AM

Hunterdon County Polytech, Flemington

Polytech Open House

Education

AtlantiCast

AtlantiCast: Episode 010

On this week’s AtlantiCast, we take you to the groundbreaking for an expansion to Morristown Medical Center, introduce you to the newest babies of 2018 at Atlantic Health System and share some must-see winter weather tips!

 

'Affordable' Housing Deal Signed Without Public Input

January 16, 2018

To the editor:

Across New Jersey the Fair Share Housing Center – a group of lawyers who make their money building and renting affordable housing – is threatening and suing towns in a blatant attempt to control local zoning. While all towns must fulfill an obligation to provide affordable housing, FSHC has now become the arbiter of “how much” and is ...

Brain Cancer Study Opens at Overlook Medical Center

January 16, 2018

Kurt Jaeckle, MD, co-director of the Gerald J. Glasser Brain Tumor Center at Overlook Medical Center, and medical director of the Atlantic Center for Research, is leading a phase III study of novel drug VAL-083, which has already shown promise in Glioblastoma and other cancers. The study is for patients whose glioblastoma multiforme or gliosarcoma has progressed during or after treatment with the ...